UBS Group’s AllianzIM U.S. Equity Buffer10 Dec ETF DECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$995 Buy
+28
New +$1.02K ﹤0.01% 9660
2025
Q4
Sell
-7
Closed -$248 10617
2025
Q3
$248 Sell
7
-993
-99% -$34.1K ﹤0.01% 9784
2025
Q2
$33.4K Sell
1,000
-1,260
-56% -$39.7K ﹤0.01% 8088
2025
Q1
$70.1K Buy
+2,260
New +$72.3K ﹤0.01% 7327
2024
Q4
Sell
-168
Closed -$5.35K 10007
2024
Q3
$5.35K Buy
+168
New +$5.26K ﹤0.01% 8063
2024
Q2
Sell
-108
Closed -$3.25K 9616
2024
Q1
$3.25K Buy
+108
New +$3.17K ﹤0.01% 7755
2023
Q4
Sell
-23
Closed -$603 9397
2023
Q3
$603 Buy
+23
New +$625 ﹤0.01% 8383
2023
Q2
Sell
-3,464
Closed -$88K 9028
2023
Q1
$88K Buy
+3,464
New +$86.1K ﹤0.01% 6006

Other funds holding DECT

UBS Group's DECT Position: Q1 2026 in Review

UBS Group opened a new position in AllianzIM U.S. Equity Buffer10 Dec ETF (DECT) in Q1 2026: 28 shares worth $995. The stake represents ﹤0.01% of the portfolio and ranks #9660 among its holdings. This is a return to the name: UBS Group previously reported a position in DECT as recently as Q3 2025.

UBS Group first reported a position in DECT in Q1 2023 and has held it in 8 quarters since. The position peaked at $88K in Q1 2023. 41 funds tracked by Wall St. Rank hold DECT as of Q1 2026.

  • UBS Group held 28 shares of AllianzIM U.S. Equity Buffer10 Dec ETF worth $995 as of Q1 2026.
  • AllianzIM U.S. Equity Buffer10 Dec ETF was a new UBS Group position in Q1 2026.
  • AllianzIM U.S. Equity Buffer10 Dec ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9660 holding.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer10 Dec ETF in Q1 2023 and has held it in 8 quarters since.
  • UBS Group's AllianzIM U.S. Equity Buffer10 Dec ETF position peaked at $88K in Q1 2023.
  • 41 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Dec ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.